Literature DB >> 25820463

Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.

Richard J L F Lemmers1, Marlinde L van den Boogaard1, Patrick J van der Vliet1, Colleen M Donlin-Smith2, Sharon P Nations3, Claudia A L Ruivenkamp4, Patricia Heard5, Bert Bakker4, Stephen Tapscott6, Jannine D Cody5, Rabi Tawil2, Silvère M van der Maarel1.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is most often associated with variegated expression in somatic cells of the normally repressed DUX4 gene within the D4Z4-repeat array. The most common form, FSHD1, is caused by a D4Z4-repeat array contraction to a size of 1-10 units (normal range 10-100 units). The less common form, FSHD2, is characterized by D4Z4 CpG hypomethylation and is most often caused by loss-of-function mutations in the structural maintenance of chromosomes hinge domain 1 (SMCHD1) gene on chromosome 18p. The chromatin modifier SMCHD1 is necessary to maintain a repressed D4Z4 chromatin state. Here, we describe two FSHD2 families with a 1.2-Mb deletion encompassing the SMCHD1 gene. Numerical aberrations of chromosome 18 are relatively common and the majority of 18p deletion syndrome (18p-) cases have, such as these FSHD2 families, only one copy of SMCHD1. Our finding therefore raises the possibility that 18p- cases are at risk of developing FSHD. To address this possibility, we combined genome-wide array analysis data with D4Z4 CpG methylation and repeat array sizes in individuals with 18p- and conclude that approximately 1:8 18p- cases might be at risk of developing FSHD.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  D4Z4; FSHD; SMCHD1; epiallele; epigenetic modifier

Mesh:

Substances:

Year:  2015        PMID: 25820463      PMCID: PMC4475473          DOI: 10.1002/humu.22792

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  22 in total

1.  Clinical features of facioscapulohumeral muscular dystrophy 2.

Authors:  J C de Greef; R J L F Lemmers; P Camaño; J W Day; S Sacconi; M Dunand; B G M van Engelen; S Kiuru-Enari; G W Padberg; A L Rosa; C Desnuelle; S Spuler; M Tarnopolsky; S L Venance; R R Frants; S M van der Maarel; R Tawil
Journal:  Neurology       Date:  2010-10-26       Impact factor: 9.910

2.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

3.  Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Kristiaan J van der Gaag; Sofia Zuniga; Rune R Frants; Peter de Knijff; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

4.  Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome).

Authors:  P J Ferguson; S Chen; M K Tayeh; L Ochoa; S M Leal; A Pelet; A Munnich; S Lyonnet; H A Majeed; H El-Shanti
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

5.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

Review 6.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil; Silvère M Van Der Maarel
Journal:  Muscle Nerve       Date:  2006-07       Impact factor: 3.217

7.  Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD.

Authors:  Judit Balog; Peter E Thijssen; Jessica C de Greef; Bharati Shah; Baziel G M van Engelen; Kyoko Yokomori; Stephen J Tapscott; Rabi Tawil; Silvère M van der Maarel
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

8.  Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).

Authors:  Weihua Zeng; Jessica C de Greef; Yen-Yun Chen; Richard Chien; Xiangduo Kong; Heather C Gregson; Sara T Winokur; April Pyle; Keith D Robertson; John A Schmiesing; Virginia E Kimonis; Judit Balog; Rune R Frants; Alexander R Ball; Leslie F Lock; Peter J Donovan; Silvère M van der Maarel; Kyoko Yokomori
Journal:  PLoS Genet       Date:  2009-07-10       Impact factor: 5.917

9.  Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.

Authors:  Lauren Snider; Linda N Geng; Richard J L F Lemmers; Michael Kyba; Carol B Ware; Angelique M Nelson; Rabi Tawil; Galina N Filippova; Silvère M van der Maarel; Stephen J Tapscott; Daniel G Miller
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

Review 10.  Monosomy 18p.

Authors:  Catherine Turleau
Journal:  Orphanet J Rare Dis       Date:  2008-02-19       Impact factor: 4.123

View more
  14 in total

1.  Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Jeroen P Vreijling; Don Henderson; Nienke van der Stoep; Nicol Voermans; Baziel van Engelen; Frank Baas; Sabrina Sacconi; Rabi Tawil; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2018-10-15       Impact factor: 6.150

2.  SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.

Authors:  Natalie D Shaw; Harrison Brand; Zachary A Kupchinsky; Hemant Bengani; Lacey Plummer; Takako I Jones; Serkan Erdin; Kathleen A Williamson; Joe Rainger; Alexei Stortchevoi; Kaitlin Samocha; Benjamin B Currall; Donncha S Dunican; Ryan L Collins; Jason R Willer; Angela Lek; Monkol Lek; Malik Nassan; Shahrin Pereira; Tammy Kammin; Diane Lucente; Alexandra Silva; Catarina M Seabra; Colby Chiang; Yu An; Morad Ansari; Jacqueline K Rainger; Shelagh Joss; Jill Clayton Smith; Margaret F Lippincott; Sylvia S Singh; Nirav Patel; Jenny W Jing; Jennifer R Law; Nalton Ferraro; Alain Verloes; Anita Rauch; Katharina Steindl; Markus Zweier; Ianina Scheer; Daisuke Sato; Nobuhiko Okamoto; Christina Jacobsen; Jeanie Tryggestad; Steven Chernausek; Lisa A Schimmenti; Benjamin Brasseur; Claudia Cesaretti; Jose E García-Ortiz; Tatiana Pineda Buitrago; Orlando Perez Silva; Jodi D Hoffman; Wolfgang Mühlbauer; Klaus W Ruprecht; Bart L Loeys; Masato Shino; Angela M Kaindl; Chie-Hee Cho; Cynthia C Morton; Richard R Meehan; Veronica van Heyningen; Eric C Liao; Ravikumar Balasubramanian; Janet E Hall; Stephanie B Seminara; Daniel Macarthur; Steven A Moore; Koh-Ichiro Yoshiura; James F Gusella; Joseph A Marsh; John M Graham; Angela E Lin; Nicholas Katsanis; Peter L Jones; William F Crowley; Erica E Davis; David R FitzPatrick; Michael E Talkowski
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 38.330

3.  FSHD1 and FSHD2 form a disease continuum.

Authors:  Sabrina Sacconi; Audrey Briand-Suleau; Marilyn Gros; Christian Baudoin; Richard J L F Lemmers; Sophie Rondeau; Nadira Lagha; Pilvi Nigumann; Chiara Cambieri; Angela Puma; Françoise Chapon; Tanya Stojkovic; Christophe Vial; Françoise Bouhour; Michelangelo Cao; Elena Pegoraro; Philippe Petiot; Anthony Behin; Bras Marc; Bruno Eymard; Andoni Echaniz-Laguna; Pascal Laforet; Leonardo Salviati; Marc Jeanpierre; Gaël Cristofari; Silvère M van der Maarel
Journal:  Neurology       Date:  2019-04-12       Impact factor: 9.910

Review 4.  Genetic and epigenetic contributors to FSHD.

Authors:  Lucia Daxinger; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Curr Opin Genet Dev       Date:  2015-09-07       Impact factor: 5.578

5.  Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.

Authors:  Judit Balog; Remko Goossens; Richard J L F Lemmers; Kirsten R Straasheijm; Patrick J van der Vliet; Anita van den Heuvel; Chiara Cambieri; Nicolas Capet; Léonard Feasson; Veronique Manel; Julian Contet; Marjolein Kriek; Colleen M Donlin-Smith; Claudia A L Ruivenkamp; Patricia Heard; Stephen J Tapscott; Jannine D Cody; Rabi Tawil; Sabrina Sacconi; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2018-03-21       Impact factor: 6.318

6.  SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

Authors:  Richard J L F Lemmers; Nienke van der Stoep; Patrick J van der Vliet; Steven A Moore; David San Leon Granado; Katherine Johnson; Ana Topf; Volker Straub; Teresinha Evangelista; Tahseen Mozaffar; Virginia Kimonis; Natalie D Shaw; Rita Selvatici; Alessandra Ferlini; Nicol Voermans; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Meindert Lamers; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2019-06-26       Impact factor: 6.318

7.  G-quadruplex ligands mediate downregulation of DUX4 expression.

Authors:  Lukasz Ciszewski; Ngoc Lu-Nguyen; Alex Slater; Andrew Brennan; Huw E L Williams; George Dickson; Mark S Searle; Linda Popplewell
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

8.  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.

Authors:  Autumn Rieken; Aaron D Bossler; Katherine D Mathews; Steven A Moore
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

9.  Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report.

Authors:  Marie-Cécile Gaillard; Francesca Puppo; Stéphane Roche; Camille Dion; Emmanuelle Salort Campana; Virginie Mariot; Charlene Chaix; Catherine Vovan; Killian Mazaleyrat; Armand Tasmadjian; Rafaelle Bernard; Julie Dumonceaux; Shahram Attarian; Nicolas Lévy; Karine Nguyen; Frédérique Magdinier; Marc Bartoli
Journal:  BMC Med Genet       Date:  2016-09-15       Impact factor: 2.103

10.  Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4.

Authors:  Judit Balog; Peter E Thijssen; Sean Shadle; Kirsten R Straasheijm; Patrick J van der Vliet; Yvonne D Krom; Marlinde L van den Boogaard; Annika de Jong; Richard J L F Lemmers; Rabi Tawil; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.